{"id":90,"date":"2019-09-22T17:49:24","date_gmt":"2019-09-22T17:49:24","guid":{"rendered":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/chapter\/3-2-basic-concepts-of-antimicrobial-therapy\/"},"modified":"2025-01-16T22:29:16","modified_gmt":"2025-01-16T22:29:16","slug":"3-2-basic-concepts-of-antimicrobial-therapy","status":"publish","type":"chapter","link":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/chapter\/3-2-basic-concepts-of-antimicrobial-therapy\/","title":{"raw":"3.2 Basic Concepts of Antimicrobial Therapy","rendered":"3.2 Basic Concepts of Antimicrobial Therapy"},"content":{"raw":"<h2>Basic Concepts Related to Antimicrobial Therapy<\/h2>\nBefore we learn about antimicrobial medications used to treat infections, we must first understand the basics of microbiology. Let's begin with a review of bacteria. Bacteria are found in nearly every habitat on earth, including within and on humans. Most bacteria are harmless or considered helpful, but some are pathogens. A <strong>[pb_glossary id=\"493\"]pathogen [\/pb_glossary]<\/strong> is defined as an organism causing disease to its host. Pathogens, when overgrown, can cause significant health problems or even death.\n\nSpecific bacteria may be identified when a client has an infection by using a culture and sensitivity test or a gram stain test. An antibiotic is selected by the prescribing provider based on the type of bacteria and the mechanism of action of the medication. Antimicrobials are classified as broad-spectrum or narrow-spectrum, based on the variety of bacteria they effectively treat. Additionally, antibiotics are also selected based on their bacteriostatic or bactericidal actions, as well as their mechanism of action. In addition to antibiotics, antimicrobials also include medications used to treat viruses and fungi. These topics will be discussed in more detail in this section, along with the issue of antibiotic resistance.\n<h3>Culture and Sensitivity<\/h3>\nWhen a client presents with signs or symptoms of an infection, health care providers will begin the detective work needed to identify the source of the infection. A <strong>[pb_glossary id=\"494\"]culture[\/pb_glossary]<\/strong> is a test performed to examine different body substances for the presence of bacteria or fungus.<sup>[footnote]This work is a derivative of <a href=\"https:\/\/cnx.org\/contents\/5CvTdmJL@7.1:rFziotaH@5\/Introduction\" target=\"_blank\" rel=\"noopener noreferrer\">Microbiology<\/a> by <a href=\"https:\/\/openstax.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">OpenStax<\/a> licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a>[\/footnote]<\/sup> These culture samples are commonly collected from a client's blood, urine, sputum, or wound bed.\n\nNurses are typically responsible for the collection of culture samples and must be conscientious to collect an accurate sample and to obtain the sample prior to the administration of antibiotics. Antibiotic administration prior to obtaining a sample causes inaccurate culture results and can complicate the client's recovery.\n\nAfter culture samples are collected, they are incubated in a solution that promotes bacterial or fungal growth and spread onto a special culture plate.<sup>[footnote]Kristof, K., &amp; Pongracz, J. (2016). Interpretation of blood microbiology results - function of the clinical microbiologist. <em>The Journal of the International Federation of Clinical Chemistry and Laboratory Medicine, 27<\/em>(2), 147-155. <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4975230\/\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4975230\/<\/a>[\/footnote]<\/sup> Clinical microbiologists subsequently monitor the culture for signs of organism growth to aid in the diagnosis of the infectious pathogen. For this reason, it typically takes a one to five days for a client's culture results to be reported by the lab.\n\nA <strong>[pb_glossary id=\"495\"] sensitivity analysis [\/pb_glossary]<\/strong> is often performed to select an effective antibiotic to treat the microorganism. If the organism shows <strong>[pb_glossary id=\"496\"]resistance [\/pb_glossary]<\/strong> to the antibiotics used in the test, the provider knows these antibiotics will not provide effective treatment for the client's infection.\n\nSometimes a client may begin antibiotic treatment for an infection based on common bacterial causes, but after the culture and sensitivity results are reported, the client is switched to a different, more effective antibiotic based on the culture and sensitivity results. The nurse is responsible for monitoring culture and sensitivity results to ensure the prescribed antibiotic therapy is effective and notifying the prescribing provider of any concerns.<sup>[footnote]Vorvick, L. (Ed.). (2019, February 7). <em>Sensitivity analysis.<\/em> <a href=\"https:\/\/medlineplus.gov\/ency\/article\/003741.htm\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/medlineplus.gov\/ency\/article\/003741.htm<\/a> [\/footnote]<\/sup>\n<h3>Gram-Positive vs. Gram-Negative<\/h3>\nA <strong>[pb_glossary id=\"497\"]gram stain [\/pb_glossary]<\/strong> is another type of test that is used to assist in classification of bacteria. Gram stains are useful for quickly identifying if bacteria are \u201c<strong>[pb_glossary id=\"729\"]gram-positive[\/pb_glossary]<\/strong>\u201d or \u201c<strong>[pb_glossary id=\"728\"]gram-negative[\/pb_glossary]<\/strong>,\u201d based on the staining patterns of their cellular walls. Utilizing gram stain allows microbiologists to look for characteristic staining patterns when they examine organisms under a microscope, with a violet color for gram-positive infections or a red\/pink color for gram-negative infections.<sup>[footnote]This work is a derivative of <a href=\"https:\/\/cnx.org\/contents\/5CvTdmJL@7.1:rFziotaH@5\/Introduction\" target=\"_blank\" rel=\"noopener noreferrer\">Microbiology<\/a> by <a href=\"https:\/\/openstax.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">OpenStax<\/a> licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a>[\/footnote]<\/sup> Identification of bacteria as gram-positive or gram-negative assists the health care provider in quickly selecting an appropriate antibiotic to treat the infection, without waiting for culture and sensitivity results.\n<h4>Sample Gram-Positive Infections<\/h4>\nExamples of gram-positive bacteria are <em>Streptococcus<\/em> and <em>Staphylococcus<\/em>. <em>Streptococcus<\/em>, whose name which comes from the Greek word for \"twisted chain,\" is responsible for many types of infectious diseases in humans, especially in the skin or soft tissues.\n\n<em>Streptococcus pyogenes<\/em> is a type of \u03b2-hemolytic <em>Streptococcus.<\/em> This species is considered a \"pyogenic pathogen\" because of the associated pus production observed with infections it causes (see Figure 3.1<sup>[footnote]\u201c<a href=\"https:\/\/commons.wikimedia.org\/wiki\/File:OSC_Microbio_04_04_Strep.jpg\" target=\"_blank\" rel=\"noopener noreferrer\">OSC Microbio 04 04 Strep.jpg<\/a>\u201d by CNX OpenStax is licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/4-4-gram-positive-bacteria\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/4-4-gram-positive-bacteria<\/a>[\/footnote]<\/sup> for an image of <em>Streptococcus<\/em> undergoing gram staining). <em>Streptococcus pyogenes<\/em> is the most common cause of bacterial pharyngitis (i.e., strep throat); it is also a common cause of various skin infections that can be relatively mild (e.g., impetigo) or life-threatening (e.g., necrotizing fasciitis, also known as flesh-eating disease).<sup>[footnote]This work is a derivative of <a href=\"https:\/\/cnx.org\/contents\/5CvTdmJL@7.1:rFziotaH@5\/Introduction\" target=\"_blank\" rel=\"noopener noreferrer\">Microbiology<\/a> by <a href=\"https:\/\/openstax.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">OpenStax<\/a> licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a>[\/footnote]<\/sup>\n\n[caption id=\"attachment_89\" align=\"aligncenter\" width=\"300\"]<img class=\"wp-image-85 size-medium\" title=\"&quot;OSC Microbio 04 04 Strep.jpg&quot; by CNX OpenStax is licensed under CC BY 4.0 Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/4-4-gram-positive-bacteria\" src=\"https:\/\/pressbooks.ccconline.org\/accdigitalmarketing\/wp-content\/uploads\/sites\/219\/2019\/09\/Gram-Stain-Specimen-300x151.png\" alt=\"Photos of Gram Stain Specimins\" width=\"300\" height=\"151\"> Figure 3.1 Gram Stain Specimen Streptococcus[\/caption]\n\n<em>Staphylococcus<\/em> is a second example of a gram-positive bacteria. The bacteria <em>Staphylococcus<\/em> comes from a Greek word for \"bunches of grapes,\" which describes their microscopic appearance in culture. Strains of <em>Staphylococcus aureus<\/em> cause a wide variety of infections in humans, including skin infections that produce boils, carbuncles, cellulitis, or impetigo.\u00a0See Figure 3.2<sup>[footnote]This work is a derivative of \u201c<a href=\"https:\/\/commons.wikimedia.org\/wiki\/File:CDC-10046-MRSA.jpg\" target=\"_blank\" rel=\"noopener noreferrer\">CDC-10046-MRSA.jpg<\/a>\u201d by Janice Haney Carr, Centers for Disease Control and Prevention and is licensed under <a href=\"https:\/\/creativecommons.org\/share-your-work\/public-domain\/cc0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC0<\/a>[\/footnote]<\/sup> for an image of <em>Staphylococcus<\/em> bacteria microscopically.\n\n[caption id=\"attachment_89\" align=\"aligncenter\" width=\"300\"]<img class=\"wp-image-86 size-medium\" title=\"This work is a derivative of &quot;CDC-10046-MRSA.jpg&quot; by Janice Haney Carr, Centers for Disease Control and Prevention is licensed under CC0\" src=\"https:\/\/pressbooks.ccconline.org\/accdigitalmarketing\/wp-content\/uploads\/sites\/219\/2025\/01\/Staphylococcus-aureus-300x202.png\" alt=\"Photo of Staphylococcus auerus\" width=\"300\" height=\"202\"> Figure 3.2 Staphylococcus Aureus[\/caption]\n\nMany strains of <em>Staphylococcus aureus<\/em> have developed resistance to many antibiotics. Examples of antibiotic-resistant strains are <strong>[pb_glossary id=\"499\"] methicillin-resistant Staphylococcus aureus (MRSA) [\/pb_glossary]<\/strong> and<strong> [pb_glossary id=\"500\"]vancomycin-resistant Staphylococcus aureus (VRSA) [\/pb_glossary]<\/strong>. Antibiotic resistant strains are difficult to treat because they exhibit resistance to nearly all available antibiotics. Because they are difficult to treat with antibiotics, infections can be lethal. MRSA and VRSA are also very contagious, posing a serious threat in hospitals, nursing homes, dialysis facilities, and other places where there are large populations of elderly, bedridden, and\/or immunocompromised clients.<sup>[footnote]This work is a derivative of <a href=\"https:\/\/cnx.org\/contents\/5CvTdmJL@7.1:rFziotaH@5\/Introduction\" target=\"_blank\" rel=\"noopener noreferrer\">Microbiology<\/a> by <a href=\"https:\/\/openstax.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">OpenStax<\/a> licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a>[\/footnote]<\/sup>\n<h4>Sample Gram-Negative Infections<\/h4>\nGram-negative bacteria have a great ability to cause disease in humans and can infect almost all body systems, such as the digestive system, nervous system, urinary system, and bloodstream. A common gram-negative bacterium is <em>Escherichia coli<\/em> (E. coli). E. coli is a common cause of urinary tract infections due to its normal presence in the gastrointestinal tract that can contaminate the urinary tract and cause infection.\n\nOther gram-negative bacteria can cause severe, sometimes life-threatening, disease. The genus <em>Neisseria<\/em>, for example, includes the bacteria <em>Neisseria gonorrhoeae <\/em>and\u00a0causes the sexually transmitted infection gonorrhea, and <em>Neisseria meningitidis <\/em>causes\u00a0bacterial meningitis. See Figure 3.3<sup>[footnote]\u201c<a href=\"https:\/\/commons.wikimedia.org\/wiki\/File:OSC_Microbio_04_02_Neisseria.jpg\" target=\"_blank\" rel=\"noopener noreferrer\">OSC Microbio 04 02 Neisseria.jpg<\/a>\u201d by <a href=\"https:\/\/cnx.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">CNX OpenStax<\/a> is licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/4-2-proteobacteria\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/4-2-proteobacteria<\/a>[\/footnote]<\/sup> for an image of <em>Neisseria meningitides<\/em>.\n\n[caption id=\"attachment_89\" align=\"aligncenter\" width=\"300\"]<img class=\"wp-image-87 size-medium\" title=\"&quot;OSC Microbio 04 02 Neisseria.jpg&quot; by CNX OpenStax is licensed under CC BY 4.0 Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/4-2-proteobacteria\" src=\"https:\/\/pressbooks.ccconline.org\/accdigitalmarketing\/wp-content\/uploads\/sites\/219\/2025\/01\/Neisseria-meningitidis-300x165.png\" alt=\"Photo shoing Neisseria meningitidis growing in colonies on a chocolate agar plate\" width=\"300\" height=\"165\"> Figure 3.3 Neisseria Meningitidis[\/caption]\n<h3>Broad-Spectrum vs. Narrow-Spectrum Antimicrobials<\/h3>\nThe spectrum of activity of an antibiotic is considered by providers when selecting an antibiotic to treat a client's infection. A <strong>[pb_glossary id=\"501\"]narrow-spectrum antimicrobial [\/pb_glossary]<\/strong> targets only specific subsets of bacterial pathogens.<sup>[footnote]This work is a derivative of <a href=\"https:\/\/cnx.org\/contents\/5CvTdmJL@7.1:rFziotaH@5\/Introduction\" target=\"_blank\" rel=\"noopener noreferrer\">Microbiology<\/a> by <a href=\"https:\/\/openstax.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">OpenStax<\/a> licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a>[\/footnote]<\/sup> For example, some narrow-spectrum drugs target gram-positive bacteria whereas others target gram-negative bacteria.\n\nA <strong>[pb_glossary id=\"502\"]broad-spectrum antimicrobial [\/pb_glossary]<\/strong> targets a wide variety of bacterial pathogens, including both gram-positive and gram-negative species. There are many reasons why a broad-spectrum antibiotic is prescribed. Broad-spectrum antibiotics may be prescribed while culture results are pending and then a narrow-spectrum antibiotic may be prescribed based on the culture and sensitivity results. Broad-spectrum antimicrobials are also used for polymicrobial infections (mixed infections with multiple bacterial species) or to prevent infections that may occur from surgery or invasive procedures. Additionally, broad-spectrum antimicrobials may be selected to treat an infection that has not responded to a narrow-spectrum antibiotic because of presumed antibiotic resistance.<sup>[footnote]This work is a derivative of <a href=\"https:\/\/cnx.org\/contents\/5CvTdmJL@7.1:rFziotaH@5\/Introduction\" target=\"_blank\" rel=\"noopener noreferrer\">Microbiology<\/a> by <a href=\"https:\/\/openstax.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">OpenStax<\/a> licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a>[\/footnote]<\/sup>\n<h4>Effects on Microbiome and Potential Superinfection<\/h4>\nA risk of using broad-spectrum antibiotics is they affect an individual's microbiome. An individual's microbiome consists of microbes that are both helpful and potentially harmful. Most are symbiotic (where both the human body and microbiota benefit), but some are pathogenic and cause disease. Broad-spectrum antibiotics can cause a disturbance in the balance between symbiotic and harmful microbiota, resulting in disease.<sup>[footnote]Harvard T.H. Chan School of Public Health. (n.d.). The Microbiome. <a href=\"https:\/\/www.hsph.harvard.edu\/nutritionsource\/microbiome\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.hsph.harvard.edu\/nutritionsource\/microbiome\/<\/a>[\/footnote]<\/sup>\n\nFor example, in the vagina, normal flora compete with opportunistic pathogens like <em>Candida albicans<\/em>. This competition prevents yeast infection by limiting the availability of nutrients and inhibiting the growth of <em>Candida<\/em>, keeping its population in check. However, when this balance is disrupted by an antibiotic, a yeast infection can occur.\n\nSimilar competitions occur between normal flora and potential pathogens in the gastrointestinal tract. Treatment with antibiotics can significantly deplete the normal flora of the gastrointestinal tract, providing an opportunity for pathogenic bacteria such as <strong>[pb_glossary id=\"631\"]Clostridium difficile (C-diff)[\/pb_glossary]<\/strong> to cause diarrheal infection. Diarrhea caused by C-diff can be severe and potentially lethal. Interestingly, a recent strategy for treating recurrent C-diff infections focuses on restoring normal flora by transplanting fecal matter from a healthy donor with normal flora. See Figure 3.4<sup>[footnote]This work is a derivative of \u201c<a href=\"https:\/\/commons.wikimedia.org\/wiki\/File:Clostridium_difficile_01.jpg\" target=\"_blank\" rel=\"noopener noreferrer\">Clostridium difficile 01.jpg<\/a>\u201d by Lois D. Wiggs at Centers of Disease Control and Prevention and is licensed under <a href=\"https:\/\/creativecommons.org\/share-your-work\/public-domain\/cc0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC0<\/a>[\/footnote]<\/sup> for an image of C-diff microscopically.\n\n[caption id=\"attachment_89\" align=\"aligncenter\" width=\"300\"]<img class=\"wp-image-88 size-medium\" title=\"This work is a derivative of &quot;Clostridium difficile 01.jpg&quot; by Lois D Wiggs at Centers of Disease Control and Prevention is licensed under CC0\" src=\"https:\/\/pressbooks.ccconline.org\/accdigitalmarketing\/wp-content\/uploads\/sites\/219\/2025\/01\/Clostridium-difficile-300x177.png\" alt=\"Photo of Clostridium difficile\" width=\"300\" height=\"177\"> Figure 3.4 Clostridium Difficile[\/caption]\n\nAn infection caused by a disruption of the individual's microbiome is also referred to as a <strong>[pb_glossary id=\"503\"]superinfection [\/pb_glossary]<\/strong> (i.e., a secondary infection in a client having a preexisting infection). A superinfection develops when the antibiotic intended for the existing infection also kills the protective microbiome. An example of a severe superinfection is pseudomembranous colitis caused by C-diff, which can be fatal.<sup>[footnote]This work is a derivative of <a href=\"https:\/\/cnx.org\/contents\/5CvTdmJL@7.1:rFziotaH@5\/Introduction\">Microbiology<\/a> by <a href=\"https:\/\/openstax.org\/\">OpenStax<\/a> licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a>[\/footnote]<\/sup>\n\nProbiotics, such as lactobacillus, are commonly recommended for individuals taking antibiotics to restore normal flora into the gastrointestinal system and prevent diarrhea, yeast infections, and other superinfections.\n<h4>Recap<\/h4>\n<ul>\n \t<li>A broad-spectrum antibiotic treats gram-positive <strong>and<\/strong> gram-negative bacteria.<\/li>\n \t<li>A narrow-spectrum antibiotic treats <strong>either<\/strong> gram-positive <strong>or<\/strong> gram-negative bacteria.<\/li>\n \t<li>Broad-spectrum antibiotics impact the individual's microbiome and can cause diarrhea and secondary infections like yeast infections (<em>Candida<\/em>) or C-diff. Probiotics may be prescribed to maintain an individual's microbiome.<\/li>\n \t<li>If a client is started on an antibiotic that treats gram-positive infection, but the culture results identify a gram-negative organism, the medication will not improve the client's status.<\/li>\n \t<li>At times, a broad-spectrum antibiotic may be prescribed prior to receiving the culture results due to the severity of the illness of the client. After the culture results are reported, the antibiotic therapy is then tailored to the client.<\/li>\n \t<li>It is the nurse's responsibility to review culture results, ensure the results have been communicated to the prescribing provider, and request a different antibiotic is prescribed if indicated.<\/li>\n<\/ul>\n<h3>Antibacterial Actions<\/h3>\n<h4>Bacteriostatic vs. Bactericidal<\/h4>\nAntibiotics are selected by providers based on how and where the drug targets the bacteria. Antibiotics can be either bacteriostatic or bactericidal in how they target bacteria. <strong>[pb_glossary id=\"504\"]Bacteriostatic [\/pb_glossary]<\/strong> drugs cause bacteria to stop reproducing but they may not kill the existing bacteria. In contrast, <strong>[pb_glossary id=\"505\"]bactericidal [\/pb_glossary]<\/strong> drugs kill targeted bacteria.\n\nThe decision about whether to use a bacteriostatic or bactericidal drug often depends on the type of infection and the overall immune status of the client. In a healthy client with strong immune defenses, both bacteriostatic and bactericidal drugs can be effective. However, when a client is immunocompromised, a bactericidal drug is often required for successful treatment of infections. Additionally, life-threatening infections in any client, such as acute bacterial endocarditis, require bactericidal drugs to eliminate all offending bacteria.<sup>[footnote]This work is a derivative of <a href=\"https:\/\/cnx.org\/contents\/5CvTdmJL@7.1:rFziotaH@5\/Introduction\" target=\"_blank\" rel=\"noopener noreferrer\">Microbiology<\/a> by <a href=\"https:\/\/openstax.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">OpenStax<\/a> licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a>[\/footnote]<\/sup>\n<h4>Mechanism of Action<\/h4>\nAnother consideration in antibiotic treatment is the drug's mechanism of action. Each class of antibacterial drugs has a unique mechanism of action at the cellular level. For example, cephalosporins act on the integrity of the cell wall. In contrast, aminoglycosides impact ribosome function and inhibit protein synthesis, which stops the proliferation of cells.<sup>[footnote]This work is a derivative of <a href=\"https:\/\/cnx.org\/contents\/5CvTdmJL@7.1:rFziotaH@5\/Introduction\" target=\"_blank\" rel=\"noopener noreferrer\">Microbiology<\/a> by <a href=\"https:\/\/openstax.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">OpenStax<\/a> licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a>[\/footnote]<\/sup> See Figure 3.5<sup>[footnote]\u201c<a href=\"https:\/\/s3-us-west-2.amazonaws.com\/courses-images\/wp-content\/uploads\/sites\/1094\/2016\/11\/03165210\/OSC_Microbio_14_02_Modes.jpg\" target=\"_blank\" rel=\"noopener noreferrer\">OSC Microbio 14 02 Modes.jpg<\/a>\u201d by <a href=\"https:\/\/cnx.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">CNX Openstax<\/a> is licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/14-3-mechanisms-of-antibacterial-drugs\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/14-3-mechanisms-of-antibacterial-drugs<\/a>[\/footnote]<\/sup> for a summary of how various antibiotics affect the cell wall, the plasma membrane, the ribosomes, the metabolic pathways, or DNA synthesis of bacteria.\n\n[caption id=\"attachment_89\" align=\"aligncenter\" width=\"737\"]<img class=\"wp-image-89\" title=\"&quot;OSC Microbio 14 02 Modes.jpg&quot; by CNX Openstax is licensed under CC BY 4.0 Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/14-3-mechanisms-of-antibacterial-drugs\" src=\"https:\/\/pressbooks.ccconline.org\/accdigitalmarketing\/wp-content\/uploads\/sites\/219\/2025\/01\/Mechanisms-of-Action.png\" alt=\"Illustration of various mechanisms of actions of antimicrobial medication with labels\" width=\"737\" height=\"475\"> Figure 3.5 Various Mechanisms of Action of Antimicrobial Medication[\/caption]\n<h3>Antiviral Medications<\/h3>\nSimilar to antibacterial medications, <strong>[pb_glossary id=\"630\"]antiviral[\/pb_glossary]<\/strong> antiviral drugs directly impact the reproduction of viruses. Unlike antimicrobials, antiviral medications do not kill the offending virus, but reduce replication and development of the virus. For example, oseltamivir (Tamiflu) is commonly prescribed to treat influenza.<sup>[footnote]This work is a derivative of <a href=\"https:\/\/cnx.org\/contents\/5CvTdmJL@7.1:rFziotaH@5\/Introduction\" target=\"_blank\" rel=\"noopener noreferrer\">Microbiology<\/a> by <a href=\"https:\/\/openstax.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">OpenStax<\/a> licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a>[\/footnote]<\/sup>\n<h3>Antifungal Medications<\/h3>\n<strong>[pb_glossary id=\"629\"]Antifungal[\/pb_glossary] <\/strong>agents are medications that are used to treat fungal infections. Fungal infections commonly affect surface areas of the body, such as the toes, groin, nails, or mouth. Antifungal medications work by killing the cells of the fungus or inhibiting the reproduction of the cells. Many antifungals are applied topically to the affected area. For example, tinea pedis (athlete's foot) is typically treated with a topical antifungal cream. Another example is the nystatin, commonly prescribed to treat oral thrush caused by <em>Candida albicans.<\/em> Nystatin may be prescribed as \"swish and spit\" as a topical oral treatment or \"swish and swallow\" for additional systemic effects.\n<h3>Antibiotic Resistance<\/h3>\nAlthough there is a wide availability of medications that are useful for treating infection, limited effectiveness of antibiotics is becoming an international problem. According to the Centers for Disease Control, each year in the United States, at least 2 million people are infected with an antibiotic-resistant infection, resulting in 23,000 deaths.<sup>[footnote]Centers for Disease Control and Prevention. (2022). <em>About antimicrobial resistance.<\/em> <a href=\"https:\/\/www.cdc.gov\/drugresistance\/about.html\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.cdc.gov\/drugresistance\/about.html<\/a>[\/footnote]<\/sup>\n<h4>Prevention Strategies<\/h4>\nMost antimicrobial drugs are self-administered by clients at home. Unfortunately, many clients stop taking antimicrobials once their symptoms dissipate. For example, if a ten-day course of antibiotic treatment is prescribed, some clients only take the drug for five or six days and stop when they start feeling better, unaware of the negative consequences of not completing the full course of treatment. The problem with failing to complete a full course of antibiotic treatment is it not only fails to kill the target organisms to the expected levels but also facilitates the development of drug-resistant variant of the bacteria within the body. The overprescription of antimicrobials also contributes to antibiotic resistance. Clients may demand antibiotics from their health care provider for treatment of infections not caused by bacteria, such as viral upper respiratory infections (i.e., the common cold).\n\nNonadherence to completing a full course of treatment is often increased when the recommended course of treatment is long. For example, treatment for tuberculosis (TB) typically lasts from six months to a year. Additionally, the Centers for Disease Control and Prevention (CDC) estimates that about one third of the world's population is infected with TB, most living in underdeveloped or underserved regions where antimicrobial drugs are available over the counter (OTC). The availability of OTC antibiotics may contribute further to the lack of completion of a full treatment regimen. As a direct result of these factors, multidrug-resistant strains of TB have become a significant problem.\n\nOne possible solution to preventing antibiotic resistance is directly observed therapy (DOT), which involves the supervised administration of medications to clients. Clients are either required to visit a health care facility to receive their medications, or health care professionals administer medication in clients\u2019 homes or another designated location. DOT has been implemented in many countries for the treatment of TB and has been shown to be effective.\n\nBut is DOT a practical strategy for all antibiotics? Would clients taking penicillin, for example, be more or less likely to adhere to the full course of treatment if they had to travel to a health care facility to receive each dose? An additional consideration is who would pay for the increased cost associated with DOT?\n\nAntibiotic resistance is a complex issue with no clear, easy solution. However, it is clear is that clients need extensive health teaching regarding the judicious and complete use of antibiotics to increase adherence and decrease the development of antibiotic resistance.<sup>[footnote]This work is a derivative of <a href=\"https:\/\/cnx.org\/contents\/5CvTdmJL@7.1:rFziotaH@5\/Introduction\" target=\"_blank\" rel=\"noopener noreferrer\">Microbiology<\/a> by <a href=\"https:\/\/openstax.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">OpenStax<\/a> licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a>[\/footnote]<\/sup>\n<div class=\"__UNKNOWN__\">\n<div class=\"textbox textbox--examples\"><header class=\"textbox__header\">\n<h2>Critical Thinking Activity 3.2<img class=\"alignright wp-image-36\" style=\"font-size: 14.4px;font-family: 'Encode Sans', sans-serif\" src=\"https:\/\/pressbooks.ccconline.org\/accdigitalmarketing\/wp-content\/uploads\/sites\/219\/2025\/01\/ORN-Icons_internet-copy_internet-copy-300x300-1.png\" alt=\"Image of a circle containing a speech bubble with a question mark in it\" width=\"200\" height=\"200\"><\/h2>\n<\/header>\n<div class=\"textbox__content\" style=\"text-align: left\">\n\nReflecting on current health care challenges regarding the ongoing emergence of antimicrobial-resistant organisms, what actions could you take within your nursing practice to help prevent drug resistance?\n\nNote: Answers to the Critical Thinking activities can be found in the \u201c<a href=\"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/chapter\/chapter-3\/\" target=\"_blank\" rel=\"noopener\">Answer Key<\/a>\u201d section at the end of the book.\n\n<\/div>\n<\/div>\n<\/div>\n<div class=\"textbox\">\n<h3 class=\"star\">\u00a0Interactive Activity<\/h3>\n[h5p id=\"6\"]\n\n<sup>\u201cAntimicrobial Definitions\u201d by E. Christman for <a href=\"https:\/\/www.cvtc.edu\/landing-pages\/grants\/open-rn\" target=\"_blank\" rel=\"noopener\">Open RN<\/a> is licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener\">CC BY 4.0<\/a><\/sup>\n\n<\/div>\n&nbsp;","rendered":"<h2>Basic Concepts Related to Antimicrobial Therapy<\/h2>\n<p>Before we learn about antimicrobial medications used to treat infections, we must first understand the basics of microbiology. Let&#8217;s begin with a review of bacteria. Bacteria are found in nearly every habitat on earth, including within and on humans. Most bacteria are harmless or considered helpful, but some are pathogens. A <strong><a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_90_493\">pathogen <\/a><\/strong> is defined as an organism causing disease to its host. Pathogens, when overgrown, can cause significant health problems or even death.<\/p>\n<p>Specific bacteria may be identified when a client has an infection by using a culture and sensitivity test or a gram stain test. An antibiotic is selected by the prescribing provider based on the type of bacteria and the mechanism of action of the medication. Antimicrobials are classified as broad-spectrum or narrow-spectrum, based on the variety of bacteria they effectively treat. Additionally, antibiotics are also selected based on their bacteriostatic or bactericidal actions, as well as their mechanism of action. In addition to antibiotics, antimicrobials also include medications used to treat viruses and fungi. These topics will be discussed in more detail in this section, along with the issue of antibiotic resistance.<\/p>\n<h3>Culture and Sensitivity<\/h3>\n<p>When a client presents with signs or symptoms of an infection, health care providers will begin the detective work needed to identify the source of the infection. A <strong><a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_90_494\">culture<\/a><\/strong> is a test performed to examine different body substances for the presence of bacteria or fungus.<sup><a class=\"footnote\" title=\"This work is a derivative of Microbiology by OpenStax licensed under CC BY 4.0. Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" id=\"return-footnote-90-1\" href=\"#footnote-90-1\" aria-label=\"Footnote 1\"><sup class=\"footnote\">[1]<\/sup><\/a><\/sup> These culture samples are commonly collected from a client&#8217;s blood, urine, sputum, or wound bed.<\/p>\n<p>Nurses are typically responsible for the collection of culture samples and must be conscientious to collect an accurate sample and to obtain the sample prior to the administration of antibiotics. Antibiotic administration prior to obtaining a sample causes inaccurate culture results and can complicate the client&#8217;s recovery.<\/p>\n<p>After culture samples are collected, they are incubated in a solution that promotes bacterial or fungal growth and spread onto a special culture plate.<sup><a class=\"footnote\" title=\"Kristof, K., &amp; Pongracz, J. (2016). Interpretation of blood microbiology results - function of the clinical microbiologist. The Journal of the International Federation of Clinical Chemistry and Laboratory Medicine, 27(2), 147-155. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4975230\/\" id=\"return-footnote-90-2\" href=\"#footnote-90-2\" aria-label=\"Footnote 2\"><sup class=\"footnote\">[2]<\/sup><\/a><\/sup> Clinical microbiologists subsequently monitor the culture for signs of organism growth to aid in the diagnosis of the infectious pathogen. For this reason, it typically takes a one to five days for a client&#8217;s culture results to be reported by the lab.<\/p>\n<p>A <strong><a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_90_495\"> sensitivity analysis <\/a><\/strong> is often performed to select an effective antibiotic to treat the microorganism. If the organism shows <strong><a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_90_496\">resistance <\/a><\/strong> to the antibiotics used in the test, the provider knows these antibiotics will not provide effective treatment for the client&#8217;s infection.<\/p>\n<p>Sometimes a client may begin antibiotic treatment for an infection based on common bacterial causes, but after the culture and sensitivity results are reported, the client is switched to a different, more effective antibiotic based on the culture and sensitivity results. The nurse is responsible for monitoring culture and sensitivity results to ensure the prescribed antibiotic therapy is effective and notifying the prescribing provider of any concerns.<sup><a class=\"footnote\" title=\"Vorvick, L. (Ed.). (2019, February 7). Sensitivity analysis. https:\/\/medlineplus.gov\/ency\/article\/003741.htm\" id=\"return-footnote-90-3\" href=\"#footnote-90-3\" aria-label=\"Footnote 3\"><sup class=\"footnote\">[3]<\/sup><\/a><\/sup><\/p>\n<h3>Gram-Positive vs. Gram-Negative<\/h3>\n<p>A <strong><a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_90_497\">gram stain <\/a><\/strong> is another type of test that is used to assist in classification of bacteria. Gram stains are useful for quickly identifying if bacteria are \u201c<strong><a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_90_729\">gram-positive<\/a><\/strong>\u201d or \u201c<strong><a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_90_728\">gram-negative<\/a><\/strong>,\u201d based on the staining patterns of their cellular walls. Utilizing gram stain allows microbiologists to look for characteristic staining patterns when they examine organisms under a microscope, with a violet color for gram-positive infections or a red\/pink color for gram-negative infections.<sup><a class=\"footnote\" title=\"This work is a derivative of Microbiology by OpenStax licensed under CC BY 4.0. Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" id=\"return-footnote-90-4\" href=\"#footnote-90-4\" aria-label=\"Footnote 4\"><sup class=\"footnote\">[4]<\/sup><\/a><\/sup> Identification of bacteria as gram-positive or gram-negative assists the health care provider in quickly selecting an appropriate antibiotic to treat the infection, without waiting for culture and sensitivity results.<\/p>\n<h4>Sample Gram-Positive Infections<\/h4>\n<p>Examples of gram-positive bacteria are <em>Streptococcus<\/em> and <em>Staphylococcus<\/em>. <em>Streptococcus<\/em>, whose name which comes from the Greek word for &#8220;twisted chain,&#8221; is responsible for many types of infectious diseases in humans, especially in the skin or soft tissues.<\/p>\n<p><em>Streptococcus pyogenes<\/em> is a type of \u03b2-hemolytic <em>Streptococcus.<\/em> This species is considered a &#8220;pyogenic pathogen&#8221; because of the associated pus production observed with infections it causes (see Figure 3.1<sup><a class=\"footnote\" title=\"\u201cOSC Microbio 04 04 Strep.jpg\u201d by CNX OpenStax is licensed under CC BY 4.0. Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/4-4-gram-positive-bacteria\" id=\"return-footnote-90-5\" href=\"#footnote-90-5\" aria-label=\"Footnote 5\"><sup class=\"footnote\">[5]<\/sup><\/a><\/sup> for an image of <em>Streptococcus<\/em> undergoing gram staining). <em>Streptococcus pyogenes<\/em> is the most common cause of bacterial pharyngitis (i.e., strep throat); it is also a common cause of various skin infections that can be relatively mild (e.g., impetigo) or life-threatening (e.g., necrotizing fasciitis, also known as flesh-eating disease).<sup><a class=\"footnote\" title=\"This work is a derivative of Microbiology by OpenStax licensed under CC BY 4.0. Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" id=\"return-footnote-90-6\" href=\"#footnote-90-6\" aria-label=\"Footnote 6\"><sup class=\"footnote\">[6]<\/sup><\/a><\/sup><\/p>\n<figure id=\"attachment_89\" aria-describedby=\"caption-attachment-89\" style=\"width: 300px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-85 size-medium\" title=\"&quot;OSC Microbio 04 04 Strep.jpg&quot; by CNX OpenStax is licensed under CC BY 4.0 Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/4-4-gram-positive-bacteria\" src=\"https:\/\/pressbooks.ccconline.org\/accdigitalmarketing\/wp-content\/uploads\/sites\/219\/2019\/09\/Gram-Stain-Specimen-300x151.png\" alt=\"Photos of Gram Stain Specimins\" width=\"300\" height=\"151\" srcset=\"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2019\/09\/Gram-Stain-Specimen-300x151.png 300w, https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2019\/09\/Gram-Stain-Specimen-65x33.png 65w, https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2019\/09\/Gram-Stain-Specimen-225x113.png 225w, https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2019\/09\/Gram-Stain-Specimen-350x176.png 350w, https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2019\/09\/Gram-Stain-Specimen.png 512w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><figcaption id=\"caption-attachment-89\" class=\"wp-caption-text\">Figure 3.1 Gram Stain Specimen Streptococcus<\/figcaption><\/figure>\n<p><em>Staphylococcus<\/em> is a second example of a gram-positive bacteria. The bacteria <em>Staphylococcus<\/em> comes from a Greek word for &#8220;bunches of grapes,&#8221; which describes their microscopic appearance in culture. Strains of <em>Staphylococcus aureus<\/em> cause a wide variety of infections in humans, including skin infections that produce boils, carbuncles, cellulitis, or impetigo.\u00a0See Figure 3.2<sup><a class=\"footnote\" title=\"This work is a derivative of \u201cCDC-10046-MRSA.jpg\u201d by Janice Haney Carr, Centers for Disease Control and Prevention and is licensed under CC0\" id=\"return-footnote-90-7\" href=\"#footnote-90-7\" aria-label=\"Footnote 7\"><sup class=\"footnote\">[7]<\/sup><\/a><\/sup> for an image of <em>Staphylococcus<\/em> bacteria microscopically.<\/p>\n<figure id=\"attachment_89\" aria-describedby=\"caption-attachment-89\" style=\"width: 300px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-86 size-medium\" title=\"This work is a derivative of &quot;CDC-10046-MRSA.jpg&quot; by Janice Haney Carr, Centers for Disease Control and Prevention is licensed under CC0\" src=\"https:\/\/pressbooks.ccconline.org\/accdigitalmarketing\/wp-content\/uploads\/sites\/219\/2025\/01\/Staphylococcus-aureus-300x202.png\" alt=\"Photo of Staphylococcus auerus\" width=\"300\" height=\"202\" srcset=\"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2025\/01\/Staphylococcus-aureus-300x202.png 300w, https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2025\/01\/Staphylococcus-aureus-65x44.png 65w, https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2025\/01\/Staphylococcus-aureus-225x152.png 225w, https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2025\/01\/Staphylococcus-aureus-350x236.png 350w, https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2025\/01\/Staphylococcus-aureus.png 512w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><figcaption id=\"caption-attachment-89\" class=\"wp-caption-text\">Figure 3.2 Staphylococcus Aureus<\/figcaption><\/figure>\n<p>Many strains of <em>Staphylococcus aureus<\/em> have developed resistance to many antibiotics. Examples of antibiotic-resistant strains are <strong><a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_90_499\"> methicillin-resistant Staphylococcus aureus (MRSA) <\/a><\/strong> and<strong> <a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_90_500\">vancomycin-resistant Staphylococcus aureus (VRSA) <\/a><\/strong>. Antibiotic resistant strains are difficult to treat because they exhibit resistance to nearly all available antibiotics. Because they are difficult to treat with antibiotics, infections can be lethal. MRSA and VRSA are also very contagious, posing a serious threat in hospitals, nursing homes, dialysis facilities, and other places where there are large populations of elderly, bedridden, and\/or immunocompromised clients.<sup><a class=\"footnote\" title=\"This work is a derivative of Microbiology by OpenStax licensed under CC BY 4.0. Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" id=\"return-footnote-90-8\" href=\"#footnote-90-8\" aria-label=\"Footnote 8\"><sup class=\"footnote\">[8]<\/sup><\/a><\/sup><\/p>\n<h4>Sample Gram-Negative Infections<\/h4>\n<p>Gram-negative bacteria have a great ability to cause disease in humans and can infect almost all body systems, such as the digestive system, nervous system, urinary system, and bloodstream. A common gram-negative bacterium is <em>Escherichia coli<\/em> (E. coli). E. coli is a common cause of urinary tract infections due to its normal presence in the gastrointestinal tract that can contaminate the urinary tract and cause infection.<\/p>\n<p>Other gram-negative bacteria can cause severe, sometimes life-threatening, disease. The genus <em>Neisseria<\/em>, for example, includes the bacteria <em>Neisseria gonorrhoeae <\/em>and\u00a0causes the sexually transmitted infection gonorrhea, and <em>Neisseria meningitidis <\/em>causes\u00a0bacterial meningitis. See Figure 3.3<sup><a class=\"footnote\" title=\"\u201cOSC Microbio 04 02 Neisseria.jpg\u201d by CNX OpenStax is licensed under CC BY 4.0. Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/4-2-proteobacteria\" id=\"return-footnote-90-9\" href=\"#footnote-90-9\" aria-label=\"Footnote 9\"><sup class=\"footnote\">[9]<\/sup><\/a><\/sup> for an image of <em>Neisseria meningitides<\/em>.<\/p>\n<figure id=\"attachment_89\" aria-describedby=\"caption-attachment-89\" style=\"width: 300px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-87 size-medium\" title=\"&quot;OSC Microbio 04 02 Neisseria.jpg&quot; by CNX OpenStax is licensed under CC BY 4.0 Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/4-2-proteobacteria\" src=\"https:\/\/pressbooks.ccconline.org\/accdigitalmarketing\/wp-content\/uploads\/sites\/219\/2025\/01\/Neisseria-meningitidis-300x165.png\" alt=\"Photo shoing Neisseria meningitidis growing in colonies on a chocolate agar plate\" width=\"300\" height=\"165\" srcset=\"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2025\/01\/Neisseria-meningitidis-300x165.png 300w, https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2025\/01\/Neisseria-meningitidis-65x36.png 65w, https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2025\/01\/Neisseria-meningitidis-225x123.png 225w, https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2025\/01\/Neisseria-meningitidis-350x192.png 350w, https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2025\/01\/Neisseria-meningitidis.png 512w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><figcaption id=\"caption-attachment-89\" class=\"wp-caption-text\">Figure 3.3 Neisseria Meningitidis<\/figcaption><\/figure>\n<h3>Broad-Spectrum vs. Narrow-Spectrum Antimicrobials<\/h3>\n<p>The spectrum of activity of an antibiotic is considered by providers when selecting an antibiotic to treat a client&#8217;s infection. A <strong><a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_90_501\">narrow-spectrum antimicrobial <\/a><\/strong> targets only specific subsets of bacterial pathogens.<sup><a class=\"footnote\" title=\"This work is a derivative of Microbiology by OpenStax licensed under CC BY 4.0. Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" id=\"return-footnote-90-10\" href=\"#footnote-90-10\" aria-label=\"Footnote 10\"><sup class=\"footnote\">[10]<\/sup><\/a><\/sup> For example, some narrow-spectrum drugs target gram-positive bacteria whereas others target gram-negative bacteria.<\/p>\n<p>A <strong><a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_90_502\">broad-spectrum antimicrobial <\/a><\/strong> targets a wide variety of bacterial pathogens, including both gram-positive and gram-negative species. There are many reasons why a broad-spectrum antibiotic is prescribed. Broad-spectrum antibiotics may be prescribed while culture results are pending and then a narrow-spectrum antibiotic may be prescribed based on the culture and sensitivity results. Broad-spectrum antimicrobials are also used for polymicrobial infections (mixed infections with multiple bacterial species) or to prevent infections that may occur from surgery or invasive procedures. Additionally, broad-spectrum antimicrobials may be selected to treat an infection that has not responded to a narrow-spectrum antibiotic because of presumed antibiotic resistance.<sup><a class=\"footnote\" title=\"This work is a derivative of Microbiology by OpenStax licensed under CC BY 4.0. Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" id=\"return-footnote-90-11\" href=\"#footnote-90-11\" aria-label=\"Footnote 11\"><sup class=\"footnote\">[11]<\/sup><\/a><\/sup><\/p>\n<h4>Effects on Microbiome and Potential Superinfection<\/h4>\n<p>A risk of using broad-spectrum antibiotics is they affect an individual&#8217;s microbiome. An individual&#8217;s microbiome consists of microbes that are both helpful and potentially harmful. Most are symbiotic (where both the human body and microbiota benefit), but some are pathogenic and cause disease. Broad-spectrum antibiotics can cause a disturbance in the balance between symbiotic and harmful microbiota, resulting in disease.<sup><a class=\"footnote\" title=\"Harvard T.H. Chan School of Public Health. (n.d.). The Microbiome. https:\/\/www.hsph.harvard.edu\/nutritionsource\/microbiome\/\" id=\"return-footnote-90-12\" href=\"#footnote-90-12\" aria-label=\"Footnote 12\"><sup class=\"footnote\">[12]<\/sup><\/a><\/sup><\/p>\n<p>For example, in the vagina, normal flora compete with opportunistic pathogens like <em>Candida albicans<\/em>. This competition prevents yeast infection by limiting the availability of nutrients and inhibiting the growth of <em>Candida<\/em>, keeping its population in check. However, when this balance is disrupted by an antibiotic, a yeast infection can occur.<\/p>\n<p>Similar competitions occur between normal flora and potential pathogens in the gastrointestinal tract. Treatment with antibiotics can significantly deplete the normal flora of the gastrointestinal tract, providing an opportunity for pathogenic bacteria such as <strong><a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_90_631\">Clostridium difficile (C-diff)<\/a><\/strong> to cause diarrheal infection. Diarrhea caused by C-diff can be severe and potentially lethal. Interestingly, a recent strategy for treating recurrent C-diff infections focuses on restoring normal flora by transplanting fecal matter from a healthy donor with normal flora. See Figure 3.4<sup><a class=\"footnote\" title=\"This work is a derivative of \u201cClostridium difficile 01.jpg\u201d by Lois D. Wiggs at Centers of Disease Control and Prevention and is licensed under CC0\" id=\"return-footnote-90-13\" href=\"#footnote-90-13\" aria-label=\"Footnote 13\"><sup class=\"footnote\">[13]<\/sup><\/a><\/sup> for an image of C-diff microscopically.<\/p>\n<figure id=\"attachment_89\" aria-describedby=\"caption-attachment-89\" style=\"width: 300px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-88 size-medium\" title=\"This work is a derivative of &quot;Clostridium difficile 01.jpg&quot; by Lois D Wiggs at Centers of Disease Control and Prevention is licensed under CC0\" src=\"https:\/\/pressbooks.ccconline.org\/accdigitalmarketing\/wp-content\/uploads\/sites\/219\/2025\/01\/Clostridium-difficile-300x177.png\" alt=\"Photo of Clostridium difficile\" width=\"300\" height=\"177\" srcset=\"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2025\/01\/Clostridium-difficile-300x177.png 300w, https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2025\/01\/Clostridium-difficile-65x38.png 65w, https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2025\/01\/Clostridium-difficile-225x133.png 225w, https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2025\/01\/Clostridium-difficile-350x207.png 350w, https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2025\/01\/Clostridium-difficile.png 700w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><figcaption id=\"caption-attachment-89\" class=\"wp-caption-text\">Figure 3.4 Clostridium Difficile<\/figcaption><\/figure>\n<p>An infection caused by a disruption of the individual&#8217;s microbiome is also referred to as a <strong><a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_90_503\">superinfection <\/a><\/strong> (i.e., a secondary infection in a client having a preexisting infection). A superinfection develops when the antibiotic intended for the existing infection also kills the protective microbiome. An example of a severe superinfection is pseudomembranous colitis caused by C-diff, which can be fatal.<sup><a class=\"footnote\" title=\"This work is a derivative of Microbiology by OpenStax licensed under CC BY 4.0. Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" id=\"return-footnote-90-14\" href=\"#footnote-90-14\" aria-label=\"Footnote 14\"><sup class=\"footnote\">[14]<\/sup><\/a><\/sup><\/p>\n<p>Probiotics, such as lactobacillus, are commonly recommended for individuals taking antibiotics to restore normal flora into the gastrointestinal system and prevent diarrhea, yeast infections, and other superinfections.<\/p>\n<h4>Recap<\/h4>\n<ul>\n<li>A broad-spectrum antibiotic treats gram-positive <strong>and<\/strong> gram-negative bacteria.<\/li>\n<li>A narrow-spectrum antibiotic treats <strong>either<\/strong> gram-positive <strong>or<\/strong> gram-negative bacteria.<\/li>\n<li>Broad-spectrum antibiotics impact the individual&#8217;s microbiome and can cause diarrhea and secondary infections like yeast infections (<em>Candida<\/em>) or C-diff. Probiotics may be prescribed to maintain an individual&#8217;s microbiome.<\/li>\n<li>If a client is started on an antibiotic that treats gram-positive infection, but the culture results identify a gram-negative organism, the medication will not improve the client&#8217;s status.<\/li>\n<li>At times, a broad-spectrum antibiotic may be prescribed prior to receiving the culture results due to the severity of the illness of the client. After the culture results are reported, the antibiotic therapy is then tailored to the client.<\/li>\n<li>It is the nurse&#8217;s responsibility to review culture results, ensure the results have been communicated to the prescribing provider, and request a different antibiotic is prescribed if indicated.<\/li>\n<\/ul>\n<h3>Antibacterial Actions<\/h3>\n<h4>Bacteriostatic vs. Bactericidal<\/h4>\n<p>Antibiotics are selected by providers based on how and where the drug targets the bacteria. Antibiotics can be either bacteriostatic or bactericidal in how they target bacteria. <strong><a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_90_504\">Bacteriostatic <\/a><\/strong> drugs cause bacteria to stop reproducing but they may not kill the existing bacteria. In contrast, <strong><a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_90_505\">bactericidal <\/a><\/strong> drugs kill targeted bacteria.<\/p>\n<p>The decision about whether to use a bacteriostatic or bactericidal drug often depends on the type of infection and the overall immune status of the client. In a healthy client with strong immune defenses, both bacteriostatic and bactericidal drugs can be effective. However, when a client is immunocompromised, a bactericidal drug is often required for successful treatment of infections. Additionally, life-threatening infections in any client, such as acute bacterial endocarditis, require bactericidal drugs to eliminate all offending bacteria.<sup><a class=\"footnote\" title=\"This work is a derivative of Microbiology by OpenStax licensed under CC BY 4.0. Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" id=\"return-footnote-90-15\" href=\"#footnote-90-15\" aria-label=\"Footnote 15\"><sup class=\"footnote\">[15]<\/sup><\/a><\/sup><\/p>\n<h4>Mechanism of Action<\/h4>\n<p>Another consideration in antibiotic treatment is the drug&#8217;s mechanism of action. Each class of antibacterial drugs has a unique mechanism of action at the cellular level. For example, cephalosporins act on the integrity of the cell wall. In contrast, aminoglycosides impact ribosome function and inhibit protein synthesis, which stops the proliferation of cells.<sup><a class=\"footnote\" title=\"This work is a derivative of Microbiology by OpenStax licensed under CC BY 4.0. Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" id=\"return-footnote-90-16\" href=\"#footnote-90-16\" aria-label=\"Footnote 16\"><sup class=\"footnote\">[16]<\/sup><\/a><\/sup> See Figure 3.5<sup><a class=\"footnote\" title=\"\u201cOSC Microbio 14 02 Modes.jpg\u201d by CNX Openstax is licensed under CC BY 4.0. Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/14-3-mechanisms-of-antibacterial-drugs\" id=\"return-footnote-90-17\" href=\"#footnote-90-17\" aria-label=\"Footnote 17\"><sup class=\"footnote\">[17]<\/sup><\/a><\/sup> for a summary of how various antibiotics affect the cell wall, the plasma membrane, the ribosomes, the metabolic pathways, or DNA synthesis of bacteria.<\/p>\n<figure id=\"attachment_89\" aria-describedby=\"caption-attachment-89\" style=\"width: 737px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-89\" title=\"&quot;OSC Microbio 14 02 Modes.jpg&quot; by CNX Openstax is licensed under CC BY 4.0 Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/14-3-mechanisms-of-antibacterial-drugs\" src=\"https:\/\/pressbooks.ccconline.org\/accdigitalmarketing\/wp-content\/uploads\/sites\/219\/2025\/01\/Mechanisms-of-Action.png\" alt=\"Illustration of various mechanisms of actions of antimicrobial medication with labels\" width=\"737\" height=\"475\" srcset=\"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2025\/01\/Mechanisms-of-Action.png 512w, https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2025\/01\/Mechanisms-of-Action-300x193.png 300w, https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2025\/01\/Mechanisms-of-Action-65x42.png 65w, https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2025\/01\/Mechanisms-of-Action-225x145.png 225w, https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2025\/01\/Mechanisms-of-Action-350x226.png 350w\" sizes=\"auto, (max-width: 737px) 100vw, 737px\" \/><figcaption id=\"caption-attachment-89\" class=\"wp-caption-text\">Figure 3.5 Various Mechanisms of Action of Antimicrobial Medication<\/figcaption><\/figure>\n<h3>Antiviral Medications<\/h3>\n<p>Similar to antibacterial medications, <strong><a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_90_630\">antiviral<\/a><\/strong> antiviral drugs directly impact the reproduction of viruses. Unlike antimicrobials, antiviral medications do not kill the offending virus, but reduce replication and development of the virus. For example, oseltamivir (Tamiflu) is commonly prescribed to treat influenza.<sup><a class=\"footnote\" title=\"This work is a derivative of Microbiology by OpenStax licensed under CC BY 4.0. Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" id=\"return-footnote-90-18\" href=\"#footnote-90-18\" aria-label=\"Footnote 18\"><sup class=\"footnote\">[18]<\/sup><\/a><\/sup><\/p>\n<h3>Antifungal Medications<\/h3>\n<p><strong><a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_90_629\">Antifungal<\/a> <\/strong>agents are medications that are used to treat fungal infections. Fungal infections commonly affect surface areas of the body, such as the toes, groin, nails, or mouth. Antifungal medications work by killing the cells of the fungus or inhibiting the reproduction of the cells. Many antifungals are applied topically to the affected area. For example, tinea pedis (athlete&#8217;s foot) is typically treated with a topical antifungal cream. Another example is the nystatin, commonly prescribed to treat oral thrush caused by <em>Candida albicans.<\/em> Nystatin may be prescribed as &#8220;swish and spit&#8221; as a topical oral treatment or &#8220;swish and swallow&#8221; for additional systemic effects.<\/p>\n<h3>Antibiotic Resistance<\/h3>\n<p>Although there is a wide availability of medications that are useful for treating infection, limited effectiveness of antibiotics is becoming an international problem. According to the Centers for Disease Control, each year in the United States, at least 2 million people are infected with an antibiotic-resistant infection, resulting in 23,000 deaths.<sup><a class=\"footnote\" title=\"Centers for Disease Control and Prevention. (2022). About antimicrobial resistance. https:\/\/www.cdc.gov\/drugresistance\/about.html\" id=\"return-footnote-90-19\" href=\"#footnote-90-19\" aria-label=\"Footnote 19\"><sup class=\"footnote\">[19]<\/sup><\/a><\/sup><\/p>\n<h4>Prevention Strategies<\/h4>\n<p>Most antimicrobial drugs are self-administered by clients at home. Unfortunately, many clients stop taking antimicrobials once their symptoms dissipate. For example, if a ten-day course of antibiotic treatment is prescribed, some clients only take the drug for five or six days and stop when they start feeling better, unaware of the negative consequences of not completing the full course of treatment. The problem with failing to complete a full course of antibiotic treatment is it not only fails to kill the target organisms to the expected levels but also facilitates the development of drug-resistant variant of the bacteria within the body. The overprescription of antimicrobials also contributes to antibiotic resistance. Clients may demand antibiotics from their health care provider for treatment of infections not caused by bacteria, such as viral upper respiratory infections (i.e., the common cold).<\/p>\n<p>Nonadherence to completing a full course of treatment is often increased when the recommended course of treatment is long. For example, treatment for tuberculosis (TB) typically lasts from six months to a year. Additionally, the Centers for Disease Control and Prevention (CDC) estimates that about one third of the world&#8217;s population is infected with TB, most living in underdeveloped or underserved regions where antimicrobial drugs are available over the counter (OTC). The availability of OTC antibiotics may contribute further to the lack of completion of a full treatment regimen. As a direct result of these factors, multidrug-resistant strains of TB have become a significant problem.<\/p>\n<p>One possible solution to preventing antibiotic resistance is directly observed therapy (DOT), which involves the supervised administration of medications to clients. Clients are either required to visit a health care facility to receive their medications, or health care professionals administer medication in clients\u2019 homes or another designated location. DOT has been implemented in many countries for the treatment of TB and has been shown to be effective.<\/p>\n<p>But is DOT a practical strategy for all antibiotics? Would clients taking penicillin, for example, be more or less likely to adhere to the full course of treatment if they had to travel to a health care facility to receive each dose? An additional consideration is who would pay for the increased cost associated with DOT?<\/p>\n<p>Antibiotic resistance is a complex issue with no clear, easy solution. However, it is clear is that clients need extensive health teaching regarding the judicious and complete use of antibiotics to increase adherence and decrease the development of antibiotic resistance.<sup><a class=\"footnote\" title=\"This work is a derivative of Microbiology by OpenStax licensed under CC BY 4.0. Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" id=\"return-footnote-90-20\" href=\"#footnote-90-20\" aria-label=\"Footnote 20\"><sup class=\"footnote\">[20]<\/sup><\/a><\/sup><\/p>\n<div class=\"__UNKNOWN__\">\n<div class=\"textbox textbox--examples\">\n<header class=\"textbox__header\">\n<h2>Critical Thinking Activity 3.2<img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-36\" style=\"font-size: 14.4px;font-family: 'Encode Sans', sans-serif\" src=\"https:\/\/pressbooks.ccconline.org\/accdigitalmarketing\/wp-content\/uploads\/sites\/219\/2025\/01\/ORN-Icons_internet-copy_internet-copy-300x300-1.png\" alt=\"Image of a circle containing a speech bubble with a question mark in it\" width=\"200\" height=\"200\" srcset=\"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2025\/01\/ORN-Icons_internet-copy_internet-copy-300x300-1.png 300w, https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2025\/01\/ORN-Icons_internet-copy_internet-copy-300x300-1-150x150.png 150w, https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2025\/01\/ORN-Icons_internet-copy_internet-copy-300x300-1-65x65.png 65w, https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2025\/01\/ORN-Icons_internet-copy_internet-copy-300x300-1-225x225.png 225w\" sizes=\"auto, (max-width: 200px) 100vw, 200px\" \/><\/h2>\n<\/header>\n<div class=\"textbox__content\" style=\"text-align: left\">\n<p>Reflecting on current health care challenges regarding the ongoing emergence of antimicrobial-resistant organisms, what actions could you take within your nursing practice to help prevent drug resistance?<\/p>\n<p>Note: Answers to the Critical Thinking activities can be found in the \u201c<a href=\"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/chapter\/chapter-3\/\" target=\"_blank\" rel=\"noopener\">Answer Key<\/a>\u201d section at the end of the book.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"textbox\">\n<h3 class=\"star\">\u00a0Interactive Activity<\/h3>\n<div id=\"h5p-6\">\n<div class=\"h5p-iframe-wrapper\"><iframe id=\"h5p-iframe-6\" class=\"h5p-iframe\" data-content-id=\"6\" style=\"height:1px\" src=\"about:blank\" frameBorder=\"0\" scrolling=\"no\" title=\"Module 4: Antimicrobial Flashcards\"><\/iframe><\/div>\n<\/div>\n<p><sup>\u201cAntimicrobial Definitions\u201d by E. Christman for <a href=\"https:\/\/www.cvtc.edu\/landing-pages\/grants\/open-rn\" target=\"_blank\" rel=\"noopener\">Open RN<\/a> is licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener\">CC BY 4.0<\/a><\/sup><\/p>\n<\/div>\n<p>&nbsp;<\/p>\n<hr class=\"before-footnotes clear\" \/><div class=\"footnotes\"><ol><li id=\"footnote-90-1\">This work is a derivative of <a href=\"https:\/\/cnx.org\/contents\/5CvTdmJL@7.1:rFziotaH@5\/Introduction\" target=\"_blank\" rel=\"noopener noreferrer\">Microbiology<\/a> by <a href=\"https:\/\/openstax.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">OpenStax<\/a> licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a> <a href=\"#return-footnote-90-1\" class=\"return-footnote\" aria-label=\"Return to footnote 1\">&crarr;<\/a><\/li><li id=\"footnote-90-2\">Kristof, K., &amp; Pongracz, J. (2016). Interpretation of blood microbiology results - function of the clinical microbiologist. <em>The Journal of the International Federation of Clinical Chemistry and Laboratory Medicine, 27<\/em>(2), 147-155. <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4975230\/\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4975230\/<\/a> <a href=\"#return-footnote-90-2\" class=\"return-footnote\" aria-label=\"Return to footnote 2\">&crarr;<\/a><\/li><li id=\"footnote-90-3\">Vorvick, L. (Ed.). (2019, February 7). <em>Sensitivity analysis.<\/em> <a href=\"https:\/\/medlineplus.gov\/ency\/article\/003741.htm\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/medlineplus.gov\/ency\/article\/003741.htm<\/a>  <a href=\"#return-footnote-90-3\" class=\"return-footnote\" aria-label=\"Return to footnote 3\">&crarr;<\/a><\/li><li id=\"footnote-90-4\">This work is a derivative of <a href=\"https:\/\/cnx.org\/contents\/5CvTdmJL@7.1:rFziotaH@5\/Introduction\" target=\"_blank\" rel=\"noopener noreferrer\">Microbiology<\/a> by <a href=\"https:\/\/openstax.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">OpenStax<\/a> licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a> <a href=\"#return-footnote-90-4\" class=\"return-footnote\" aria-label=\"Return to footnote 4\">&crarr;<\/a><\/li><li id=\"footnote-90-5\">\u201c<a href=\"https:\/\/commons.wikimedia.org\/wiki\/File:OSC_Microbio_04_04_Strep.jpg\" target=\"_blank\" rel=\"noopener noreferrer\">OSC Microbio 04 04 Strep.jpg<\/a>\u201d by CNX OpenStax is licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/4-4-gram-positive-bacteria\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/4-4-gram-positive-bacteria<\/a> <a href=\"#return-footnote-90-5\" class=\"return-footnote\" aria-label=\"Return to footnote 5\">&crarr;<\/a><\/li><li id=\"footnote-90-6\">This work is a derivative of <a href=\"https:\/\/cnx.org\/contents\/5CvTdmJL@7.1:rFziotaH@5\/Introduction\" target=\"_blank\" rel=\"noopener noreferrer\">Microbiology<\/a> by <a href=\"https:\/\/openstax.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">OpenStax<\/a> licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a> <a href=\"#return-footnote-90-6\" class=\"return-footnote\" aria-label=\"Return to footnote 6\">&crarr;<\/a><\/li><li id=\"footnote-90-7\">This work is a derivative of \u201c<a href=\"https:\/\/commons.wikimedia.org\/wiki\/File:CDC-10046-MRSA.jpg\" target=\"_blank\" rel=\"noopener noreferrer\">CDC-10046-MRSA.jpg<\/a>\u201d by Janice Haney Carr, Centers for Disease Control and Prevention and is licensed under <a href=\"https:\/\/creativecommons.org\/share-your-work\/public-domain\/cc0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC0<\/a> <a href=\"#return-footnote-90-7\" class=\"return-footnote\" aria-label=\"Return to footnote 7\">&crarr;<\/a><\/li><li id=\"footnote-90-8\">This work is a derivative of <a href=\"https:\/\/cnx.org\/contents\/5CvTdmJL@7.1:rFziotaH@5\/Introduction\" target=\"_blank\" rel=\"noopener noreferrer\">Microbiology<\/a> by <a href=\"https:\/\/openstax.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">OpenStax<\/a> licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a> <a href=\"#return-footnote-90-8\" class=\"return-footnote\" aria-label=\"Return to footnote 8\">&crarr;<\/a><\/li><li id=\"footnote-90-9\">\u201c<a href=\"https:\/\/commons.wikimedia.org\/wiki\/File:OSC_Microbio_04_02_Neisseria.jpg\" target=\"_blank\" rel=\"noopener noreferrer\">OSC Microbio 04 02 Neisseria.jpg<\/a>\u201d by <a href=\"https:\/\/cnx.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">CNX OpenStax<\/a> is licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/4-2-proteobacteria\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/4-2-proteobacteria<\/a> <a href=\"#return-footnote-90-9\" class=\"return-footnote\" aria-label=\"Return to footnote 9\">&crarr;<\/a><\/li><li id=\"footnote-90-10\">This work is a derivative of <a href=\"https:\/\/cnx.org\/contents\/5CvTdmJL@7.1:rFziotaH@5\/Introduction\" target=\"_blank\" rel=\"noopener noreferrer\">Microbiology<\/a> by <a href=\"https:\/\/openstax.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">OpenStax<\/a> licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a> <a href=\"#return-footnote-90-10\" class=\"return-footnote\" aria-label=\"Return to footnote 10\">&crarr;<\/a><\/li><li id=\"footnote-90-11\">This work is a derivative of <a href=\"https:\/\/cnx.org\/contents\/5CvTdmJL@7.1:rFziotaH@5\/Introduction\" target=\"_blank\" rel=\"noopener noreferrer\">Microbiology<\/a> by <a href=\"https:\/\/openstax.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">OpenStax<\/a> licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a> <a href=\"#return-footnote-90-11\" class=\"return-footnote\" aria-label=\"Return to footnote 11\">&crarr;<\/a><\/li><li id=\"footnote-90-12\">Harvard T.H. Chan School of Public Health. (n.d.). The Microbiome. <a href=\"https:\/\/www.hsph.harvard.edu\/nutritionsource\/microbiome\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.hsph.harvard.edu\/nutritionsource\/microbiome\/<\/a> <a href=\"#return-footnote-90-12\" class=\"return-footnote\" aria-label=\"Return to footnote 12\">&crarr;<\/a><\/li><li id=\"footnote-90-13\">This work is a derivative of \u201c<a href=\"https:\/\/commons.wikimedia.org\/wiki\/File:Clostridium_difficile_01.jpg\" target=\"_blank\" rel=\"noopener noreferrer\">Clostridium difficile 01.jpg<\/a>\u201d by Lois D. Wiggs at Centers of Disease Control and Prevention and is licensed under <a href=\"https:\/\/creativecommons.org\/share-your-work\/public-domain\/cc0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC0<\/a> <a href=\"#return-footnote-90-13\" class=\"return-footnote\" aria-label=\"Return to footnote 13\">&crarr;<\/a><\/li><li id=\"footnote-90-14\">This work is a derivative of <a href=\"https:\/\/cnx.org\/contents\/5CvTdmJL@7.1:rFziotaH@5\/Introduction\">Microbiology<\/a> by <a href=\"https:\/\/openstax.org\/\">OpenStax<\/a> licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a> <a href=\"#return-footnote-90-14\" class=\"return-footnote\" aria-label=\"Return to footnote 14\">&crarr;<\/a><\/li><li id=\"footnote-90-15\">This work is a derivative of <a href=\"https:\/\/cnx.org\/contents\/5CvTdmJL@7.1:rFziotaH@5\/Introduction\" target=\"_blank\" rel=\"noopener noreferrer\">Microbiology<\/a> by <a href=\"https:\/\/openstax.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">OpenStax<\/a> licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a> <a href=\"#return-footnote-90-15\" class=\"return-footnote\" aria-label=\"Return to footnote 15\">&crarr;<\/a><\/li><li id=\"footnote-90-16\">This work is a derivative of <a href=\"https:\/\/cnx.org\/contents\/5CvTdmJL@7.1:rFziotaH@5\/Introduction\" target=\"_blank\" rel=\"noopener noreferrer\">Microbiology<\/a> by <a href=\"https:\/\/openstax.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">OpenStax<\/a> licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a> <a href=\"#return-footnote-90-16\" class=\"return-footnote\" aria-label=\"Return to footnote 16\">&crarr;<\/a><\/li><li id=\"footnote-90-17\">\u201c<a href=\"https:\/\/s3-us-west-2.amazonaws.com\/courses-images\/wp-content\/uploads\/sites\/1094\/2016\/11\/03165210\/OSC_Microbio_14_02_Modes.jpg\" target=\"_blank\" rel=\"noopener noreferrer\">OSC Microbio 14 02 Modes.jpg<\/a>\u201d by <a href=\"https:\/\/cnx.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">CNX Openstax<\/a> is licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/14-3-mechanisms-of-antibacterial-drugs\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/14-3-mechanisms-of-antibacterial-drugs<\/a> <a href=\"#return-footnote-90-17\" class=\"return-footnote\" aria-label=\"Return to footnote 17\">&crarr;<\/a><\/li><li id=\"footnote-90-18\">This work is a derivative of <a href=\"https:\/\/cnx.org\/contents\/5CvTdmJL@7.1:rFziotaH@5\/Introduction\" target=\"_blank\" rel=\"noopener noreferrer\">Microbiology<\/a> by <a href=\"https:\/\/openstax.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">OpenStax<\/a> licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a> <a href=\"#return-footnote-90-18\" class=\"return-footnote\" aria-label=\"Return to footnote 18\">&crarr;<\/a><\/li><li id=\"footnote-90-19\">Centers for Disease Control and Prevention. (2022). <em>About antimicrobial resistance.<\/em> <a href=\"https:\/\/www.cdc.gov\/drugresistance\/about.html\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.cdc.gov\/drugresistance\/about.html<\/a> <a href=\"#return-footnote-90-19\" class=\"return-footnote\" aria-label=\"Return to footnote 19\">&crarr;<\/a><\/li><li id=\"footnote-90-20\">This work is a derivative of <a href=\"https:\/\/cnx.org\/contents\/5CvTdmJL@7.1:rFziotaH@5\/Introduction\" target=\"_blank\" rel=\"noopener noreferrer\">Microbiology<\/a> by <a href=\"https:\/\/openstax.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">OpenStax<\/a> licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a> <a href=\"#return-footnote-90-20\" class=\"return-footnote\" aria-label=\"Return to footnote 20\">&crarr;<\/a><\/li><\/ol><\/div><div class=\"glossary\"><span class=\"screen-reader-text\" id=\"definition\">definition<\/span><template id=\"term_90_493\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_90_493\"><div tabindex=\"-1\"><p>An organism causing disease to its host.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_90_494\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_90_494\"><div tabindex=\"-1\"><p>A test performed to examine different body substances for the presence of bacteria or fungus.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_90_495\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_90_495\"><div tabindex=\"-1\"><p>A test performed in addition to a culture in order to select an effective antibiotic to treat the microorganism.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_90_496\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_90_496\"><div tabindex=\"-1\"><p>A characteristic of bacteria demonstrated lack of effective treatment by an antibiotic when a sensitivity analysis is performed.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_90_497\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_90_497\"><div tabindex=\"-1\"><p>A test used to quickly diagnose bacterial infection. Identification of bacteria as gram + or gram - assists the health care provider in selecting an appropriate antibiotic to treat the infection.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_90_729\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_90_729\"><div tabindex=\"-1\"><p>Gram-positive bacteria are classified by the color they turn after a chemical called gram stain is applied to them. Infections caused by Streptococcus and Staphylococcus bacteria are examples of gram-positive infections.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_90_728\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_90_728\"><div tabindex=\"-1\"><p>Gram-negative bacteria are classified by the color they turn after a chemical called gram stain is applied to them. Escherichia Coli (also known as E. Coli) is an example of a gram-negative infection.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_90_499\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_90_499\"><div tabindex=\"-1\"><p>An infection caused by <em>Methicillin-resistant Staphylococcus aureus<\/em> that is difficult to treat because it exhibits resistance to nearly all available antibiotics.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_90_500\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_90_500\"><div tabindex=\"-1\"><p>An infection caused by <em>Vancomycin-resistant Staphylococcus aureus<\/em> that is difficult to treat because it exhibits resistance to nearly all available antibiotics.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_90_501\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_90_501\"><div tabindex=\"-1\"><p>An antibiotic that targets only specific subsets of bacterial pathogens.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_90_502\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_90_502\"><div tabindex=\"-1\"><p>An antibiotic that targets a wide variety of bacterial pathogens, including both gram-positive and gram-negative species.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_90_631\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_90_631\"><div tabindex=\"-1\"><p>Clostridium difficile causes pseudomembranous colitis, a superinfection that can be caused by broad spectrum antibiotic therapy.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_90_503\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_90_503\"><div tabindex=\"-1\"><p>A secondary infection in a patient having a preexisting infection. C-diff and yeast infections as a result of antibiotic therapy are examples of superinfections.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_90_504\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_90_504\"><div tabindex=\"-1\"><p>Antimicrobial drugs that cause bacteria to stop reproducing but may not ultimately kill the bacteria.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_90_505\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_90_505\"><div tabindex=\"-1\"><p>Antimicrobial drugs that kill their target bacteria.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_90_630\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_90_630\"><div tabindex=\"-1\"><p>Medications used to treat viral infections. For example, Tamiflu is used to treat influenza.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_90_629\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_90_629\"><div tabindex=\"-1\"><p>Medications that are used to treat fungal infections.\u00a0 For example, nystatin is used to treat Candida Albicans, a fungal infection.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><\/div>","protected":false},"author":83,"menu_order":2,"template":"","meta":{"pb_show_title":"on","pb_short_title":"","pb_subtitle":"","pb_authors":[],"pb_section_license":""},"chapter-type":[48],"contributor":[],"license":[],"class_list":["post-90","chapter","type-chapter","status-publish","hentry","chapter-type-numberless"],"part":82,"_links":{"self":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/90","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters"}],"about":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/types\/chapter"}],"author":[{"embeddable":true,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/users\/83"}],"version-history":[{"count":3,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/90\/revisions"}],"predecessor-version":[{"id":780,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/90\/revisions\/780"}],"part":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/parts\/82"}],"metadata":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/90\/metadata\/"}],"wp:attachment":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/media?parent=90"}],"wp:term":[{"taxonomy":"chapter-type","embeddable":true,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapter-type?post=90"},{"taxonomy":"contributor","embeddable":true,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/contributor?post=90"},{"taxonomy":"license","embeddable":true,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/license?post=90"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}